Cargando…
Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)
INTRODUCTION: HFE p.C282Y homozygosity is the most common cause of hereditary haemochromatosis. There is currently insufficient evidence to assess whether non-specific symptoms or hepatic injury in homozygotes with moderately elevated iron defined as a serum ferritin (SF) of 300–1000 µg/L are relate...
Autores principales: | Ong, Sim Yee, Dolling, Lara, Dixon, Jeannette L, Nicoll, Amanda J, Gurrin, Lyle C, Wolthuizen, Michelle, Wood, Erica M, Anderson, Greg J, Ramm, Grant A, Allen, Katrina J, Olynyk, John K, Crawford, Darrell, Kava, Jennifer, Ramm, Louise E, Gow, Paul, Durrant, Simon, Powell, Lawrie W, Delatycki, Martin B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538285/ https://www.ncbi.nlm.nih.gov/pubmed/26270952 http://dx.doi.org/10.1136/bmjopen-2015-008938 |
Ejemplares similares
-
Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis
por: Chin, Justin, et al.
Publicado: (2019) -
Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis
por: Ong, Sim Yee, et al.
Publicado: (2021) -
Relationship of Baseline Hemoglobin Level with Serum Ferritin, Postphlebotomy Hemoglobin Changes, and Phlebotomy Requirements among HFE C282Y Homozygotes
por: Mousavi, Seyed Ali, et al.
Publicado: (2015) -
Undiagnosed diabetes and impaired fasting glucose in HFE C282Y homozygotes and HFE wild-type controls in the HEIRS Study
por: Barton, James C, et al.
Publicado: (2016) -
Iron overload phenotypes and HFE genotypes in white hemochromatosis and iron overload screening study participants without HFE p.C282Y/p.C282Y
por: Barton, James C., et al.
Publicado: (2022)